FDA Approved: XENPOZYME — Original Application (Genzyme Corporation)

View source ↗

Summary

FDA approved XENPOZYME (olipudase alfa-rpcp) from Genzyme in an original application to treat acid sphingomyelinase deficiency (ASMD), including non-neurologica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acid Sphingomyelinase Deficiency
• Niemann-pick Disease Type and

Drugs mentioned

• XENPOZYME (olipudase alfa-RPCP)

Snippet

ORIG AP for XENPOZYME (OLIPUDASE ALFA-RPCP)